Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
Depression and Anxiety
|
April 21, 2015
A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder
Carl Gommoll, Suresh Durgam, Maju Mathews, et al.
Neuropsychiatric Disease and Treatment
|
December 9, 2021
Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials
Stephane Borentain, David Williamson, Ibrahim Turkoz, et al.
The Journal of Clinical Psychiatry
|
May 28, 2016
Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial
Suresh Durgam, Carl Gommoll, Giovanna Forero, et al.
International Journal of Clinical Practice
|
May 1, 2018
Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations
Alberto Russu, Jennifer Kern Sliwa, Paulien Ravenstijn, et al.
Comprehensive Psychiatry
|
March 12, 2021
Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate
Rebekka Lencer, Maria Paz Garcia-Portilla, Paul Bergmans, et al.
Neuropsychiatric Disease and Treatment
|
December 1, 2018
Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate
Maju Mathews, Isaac Nuamah, Adam J Savitz, et al.
The American Journal of Psychiatry
|
April 1, 2005
Child psychopharmacology, effect sizes, and the big bang
Maju Mathews, Babatunde Adetunji, Joanne Mathews, et al.
The American Journal of Psychiatry
|
September 27, 2017
Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder
Armin Szegedi, Suresh Durgam, Mary Mackle, et al.
International Clinical Psychopharmacology
|
March 2, 2018
Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia
Arun Singh, Srihari Gopal, Edward Kim, et al.
The Lancet. Psychiatry
|
February 24, 2020
Approval of esketamine for treatment-resistant depression
Jaskaran B Singh, Ella J Daly, Maju Mathews, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
Depression and Anxiety
|
April 21, 2015
A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder
Carl Gommoll, Suresh Durgam, Maju Mathews, et al.
Neuropsychiatric Disease and Treatment
|
December 9, 2021
Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials
Stephane Borentain, David Williamson, Ibrahim Turkoz, et al.
The Journal of Clinical Psychiatry
|
May 28, 2016
Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial
Suresh Durgam, Carl Gommoll, Giovanna Forero, et al.
International Journal of Clinical Practice
|
May 1, 2018
Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations
Alberto Russu, Jennifer Kern Sliwa, Paulien Ravenstijn, et al.
Comprehensive Psychiatry
|
March 12, 2021
Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate
Rebekka Lencer, Maria Paz Garcia-Portilla, Paul Bergmans, et al.
Neuropsychiatric Disease and Treatment
|
December 1, 2018
Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate
Maju Mathews, Isaac Nuamah, Adam J Savitz, et al.
The American Journal of Psychiatry
|
April 1, 2005
Child psychopharmacology, effect sizes, and the big bang
Maju Mathews, Babatunde Adetunji, Joanne Mathews, et al.
The American Journal of Psychiatry
|
September 27, 2017
Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder
Armin Szegedi, Suresh Durgam, Mary Mackle, et al.
International Clinical Psychopharmacology
|
March 2, 2018
Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia
Arun Singh, Srihari Gopal, Edward Kim, et al.
The Lancet. Psychiatry
|
February 24, 2020
Approval of esketamine for treatment-resistant depression
Jaskaran B Singh, Ella J Daly, Maju Mathews, et al.
Page
of 10